中文产业新闻评分66Chinese source
默沙东口服PCSK9抑制剂Lipfendra获FDA批准，市场对降脂赛道反应分化
降脂PCSK9赛道，口服剂型撬动大分化
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
降脂PCSK9赛道，口服剂型撬动大分化
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.